Cullen/Frost Bankers’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
CAM
Cullen/Frost Bankers's LMAT Position: Q2 2023 in Review
Cullen/Frost Bankers sold out of LeMaitre Vascular (LMAT) in Q2 2023, closing a stake of 149 shares — an estimated $7.67K sold.
Cullen/Frost Bankers first reported a position in LMAT in Q2 2021 and held it in 3 quarters. The position peaked at $24K in Q2 2021. 212 funds tracked by Wall St. Rank hold LMAT as of Q2 2023.
- Cullen/Frost Bankers reported no remaining LeMaitre Vascular position as of Q2 2023 after selling out during the quarter.
- Cullen/Frost Bankers sold 149 LeMaitre Vascular shares in Q2 2023, an estimated $7.67K.
- Cullen/Frost Bankers first reported a position in LeMaitre Vascular in Q2 2021 and held it in 3 quarters.
- Cullen/Frost Bankers's LeMaitre Vascular position peaked at $24K in Q2 2021.
- 212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2023.
Based on Cullen/Frost Bankers's 13F filing for Q2 2023, filed 4 Aug 2023.